Divine Nutrition


FDA Warns of High-Grade Prostate Ca Risk With BPH Drugs

Results 1 to 3 of 3
  1. #1
    Senior Member
    ADMINISTRATOR
    Prince's Avatar


    Join Date
    Nov 2000
    Gender
    Male
    Location
    Panama
    Posts
    63,839
    Rep Points
    2147483647

    FDA Warns of High-Grade Prostate Ca Risk With BPH Drugs

    FDA Warns of High-Grade Prostate Ca Risk With BPH Drugs

    EVERYTHING WILL KILL YOU! I take FINASTERIDE but I won't stop.... I don't think anyone who's healthy and taking it has anything to worry about.

    By Emily P. Walker, Washington Correspondent, MedPage Today
    Published: June 09, 2011

    WASHINGTON -- The FDA has issued a warning of an increased risk of high-grade prostate cancer with the 5-alpha reductase inhibitors finasteride (Proscar) and dutasteride (Avodart), currently approved to treat benign prostatic hypertrophy.

    The agency announced Thursday that it has updated the Warnings and Precautions section of labels for the class of drugs -- which includes branded products Propecia and Jalyn under which finasteride and dutasteride are marketed for other indications -- to reflect the increased risk.

    "This risk appears to be low, but healthcare professionals should be aware of this safety information, and weigh the known benefits against the potential risks when deciding to start or continue treatment with 5-ARIs in men," the agency wrote in its safety announcement.

    Avodart, Jalyn, and Proscar are approved to treat symptoms of an enlarged prostate. Propecia, at a 1-mg dose, is approved to treat hair loss in men.

    The announcement follows the FDA's Oncologic Drugs Advisory Committee's vote of 17-0 in December that GlaxoSmithKline's dutasteride and Merck's finasteride should not be used to prevent prostate cancer because the drugs are linked to a higher incidence of high-grade tumors.

    GlaxoSmithKline was seeking to expand dutasteride's indication to include reducing the risk of prostate cancer in men who have had a prior negative biopsy and who have an elevated PSA.

    Merck hadn't been seeking an expanded indication, but the company wanted to update the label of finasteride to detail positive results of the Prostate Cancer Prevention Trial (PCPT), which demonstrated the drug's chemopreventive potential.

    Although the 5-alpha reductase inhibitors were shown to prevent low-risk cancers better than placebo, two large clinical trials painted a disturbing link between both drugs and an increased incidence of higher-risk prostate cancers.

    Taken together, data from the trials -- the PCPT and the Reduction by Dutasteride of Prostate Cancer Events (REDUCE) trial -- showed the 5-alpha reductase inhibitors both provided a statistically significant reduction in the cumulative incidence of prostate cancer after four years (REDUCE) and seven years (PCPT) of treatment with dutasteride and finasteride, respectively.

    But both trials also found an unexpected increase in the incidence of high-grade prostate cancers among men receiving the 5-alpha reductase inhibitors.

    In the REDUCE trial, 29 high-grade tumors were found among patients being treated with dutasteride compared with 19 in the placebo group.

    In the PCPT, there was a 26% decrease in all prostate cancers but an absolute increase of 1.3% in the incidence of high-grade tumors.
    According to an FDA statistician who spoke at the December advisory committee meeting, if 200 men are treated with the drugs, it is expected that there will be one additional tumor with a Gleason score of 8 to 10.

    How to handle low-grade prostate cancer is controversial in the urology community, in part because it is unknown if the low-grade tumors would ever develop into high-grade tumors, and also because the method used to originally detect prostate cancer -- the PSA test -- is inexact.

    About five million men received a prescription for a 5-ARI between 2002 and 2009, according to the FDA.


    IronMagLabs 15% Discount Code: Robert15






    IronMag Research 15% Discount Code: Robert15



  2. #2
    Senior Member
    ELITE MEMBER
    dogsoldier's Avatar


    Join Date
    Oct 2010
    Gender
    Male
    Location
    Arizona
    Posts
    1,560
    Rep Points
    548246148

    Thanks Prince. I know this was posted last month, but I just found it. My PSA spiked over the past 6 months. The doc naturally wants to do the dreaded biopsy. Had one of those things several years ago. F*cking medieval is all I can say about that test. Went through all that just to find out it was an infection. Back then, I had no symptoms, just an elevated PSA. The doctor mentioned over the phone that he often prescribes Avodart for BPH. I am not having any problems peeing or getting waking up up in the middle of the night. It really ticks me off how doctors can just jump to conclusions like this. He is an excellent urologist and I do trust him. But when he jumps on things like he did with this, it pisses me of. I will demand a retest of the PSA. The appointment is next Thursday.

  3. #3
    inadvertant tree hugger
    ELITE MEMBER
    bandaidwoman's Avatar


    Join Date
    Dec 2003
    Location
    Atlanta, Georgia
    Posts
    1,440
    Rep Points
    59565640

    ok association is not causal and the FDA has become more of a political body than sceintific.

    Overall, men on these drugs have 26% less prostate cancers. When we put patients on these we anticipate that the PSA gets lowered by its effect on lowering the total mass of the prostate gland. I suspect these products by lowering the PSA artificially prevents that subtle early spike in PSA in people with aggressive prosate cancer. or it is a detection bias, the smaller prostates due to the medicines makes it easier to detect. see link below
    The problem is the PSA is so non specific it is high in infections, after vigorous sex, enlargement etc. and not always with cancer. They are looking for a more specific psa ( even free psa still misses the boat)

    http://www.medscape.com/viewarticle/705804

    Finasteride Does Not Increase Risk for High-Grade Prostate Cancer
    and it comments on the study the FDA is citing
    Last edited by bandaidwoman; 07-07-2011 at 06:08 AM.
    Official Race Member of the Crank Crushing Rednecks

    Eat more mud, mountain bike until you die!

    XX Feminine power

Similar Threads

  1. Replies: 0
    Last Post: 01-03-2012, 11:10 AM
  2. Replies: 6
    Last Post: 10-30-2011, 08:32 PM
  3. Coffee may help cut prostate cancer risk
    By Prince in forum Diet & Nutrition
    Replies: 4
    Last Post: 05-23-2011, 10:12 PM
  4. Testosterone seen unrelated to prostate cancer risk
    By Prince in forum Anabolic Zone
    Replies: 1
    Last Post: 02-01-2008, 08:58 AM
  5. Green tea may cut prostate cancer risk (AP)
    By RSS Feed Robot in forum General Health & Awareness
    Replies: 1
    Last Post: 12-19-2007, 08:11 PM

Posting Permissions

  • You may not post new threads
  • You may not post replies
  • You may not post attachments
  • You may not edit your posts
  •  
-->